МЕЗЕНХИМАЛЬНАЯ ДИСПЛАЗИЯ ПЛАЦЕНТЫ
- Авторы: ПАВЛОВ КА1, ДУБОВА ЕА1, ЩЕГОЛЕВ АИ1, Pavlov KA2, Dubova EA2, Shchegolev AI2
-
Учреждения:
- ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,Москва
- Выпуск: № 5 (2010)
- Страницы: 15-20
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/246335
- ID: 246335
Цитировать
Полный текст
Аннотация
Ключевые слова
Об авторах
К А ПАВЛОВ
ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,МоскваФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,Москва
Е А ДУБОВА
ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,МоскваФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,Москва
А И ЩЕГОЛЕВ
ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,МоскваФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ,Москва
K A Pavlov
E A Dubova
A I Shchegolev
Список литературы
- Allias F., Lebreton F., Collardeau-Frachon S. et al. Immunohistochemical expression of p57 in placental vascular proliferative disorders of preterm and term placentas // Fetal. Pediatr. Pathol. - 2009. - Vol. 28, № 1. - P. 9-23.
- Arizawa M., Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia // Cong. Anomal. - 2002. - Vol. 42, № 4. - P. 309-317.
- Astner A., Schwinger E., Caliebe A. et al. Sonographically detected fetal and placental abnormalities associated with trisomy 16 confined to the placenta: a case report and review of the literature // Prenat. Diagn. - 1998. - Vol. 18. - P. 1308-1315.
- Benirschke K., Kaufmann P. Pathology of the Human Placenta. 4th ed. - NY: Springer Verlag, 2000.
- Bhuiyan Z.A., Yatsuki H., Sasaguri T. et al. Functional analysis of the p57KIP2 gene mutation in Beckwith- Wiedemann syndrome // Hum. Genet. - 1999. - Vol. 104, № 3. - P. 205-210.
- Carta M., Maresi E., Giuffre M. et al. Congenital hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta: case report // J. Pediatr. Surg. - 2005. - Vol. 40, № 5. - P. e37-e39.
- Castrillon D.H., Sun D., Weremowicz S. et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2 // Am. J. Surg. Pathol. - 2001. -Vol. 25, № 10. - P. 1225-1230.
- Chan Y.F., Sampson A. Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole // Aust. N. Z. J. Obstet. Gynaecol. - 2003. - Vol. 43, № 6. - P. 475-479.
- Chen C.P. Syndromes and disorders associated with omphalocele (I): Beckwith-Wiedemann syndrome // Taiwan J. Obstet. Gynecol. - 2007. - Vol. 46, № 2. - P. 96-102.
- Chen C.P., Chern S.R., Wang T.Y. et al. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia // Hum. Reprod. - 1997. - Vol. 12, № 11. - P. 2553-2556.
- Chilosi M., Piazzola E., Lestani M. et al. Differential expression of p57Kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease // Lab. Invest. - 1998. - Vol. 78, № 3. - P. 269-276.
- Cohen M.C., Roper E.C., Sebire N.J. et al. Placental mesenchymal dysplasia associated with fetal aneuploidy // Prenat. Diagn. - 2005. - Vol. 25, № 3. - P. 187-192.
- Cohen M.M .Jr. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives // Pediatr. Dev. Pathol. - 2005. - Vol. 8, № 3. - P. 287-304.
- DeChiara T.M., Robertson E.J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene // Cell. - 1991. - Vol. 64, № 4. - P. 849-859.
- H'mida D., Gribaa M., Yacoubi T. et al. Placental mesenchymal dysplasia with Beckwith-Wiedemann syndrome fetus in the context of biparental and androgenic cell lines // Placenta. - 2008. - Vol. 29, № 5. - P. 454-460.
- Jauniaux E., Nicolaides K.H., Hustin J. Perinatal features associated with placental mesenchymal dysplasia // Placenta. - 1997. - Vol. 18, № 8. - P. 701-706.
- Joukov V., Pajusola K., Kaipainen A. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR- 2) receptor tyrosine kinases // EMBO J. - 1996. - Vol. 15, № 7. - P. 290-298.
- Kaiser-Rogers K.A., McFadden D.E., Livasy CA. et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia // J. Med. Genet. - 2006. - Vol. 43, № 2. - P. 187-192.
- Katz V.L., Blanchard G.F., Watson W.J. et al. The clinical implications of subchorionic placental lucencies // Am. J. Obstet. Gynecol. - 1991. - Vol. 164, № 1, pt 1. - P. 99-100.
- Khong T.Y. Placental vascular development and neonatal outcome // Semin. Neonatol. - 2004. - Vol. 9, № 4. - P. 255-263.
- Kuwabara Y., Shima Y., Araki T., Shin S. Mesenchymal stem villous hyperplasia of the placenta and fetal growth restriction // Obstet. Gynecol. - 2001. - Vol. 98, № 5, pt 2. - P. 940-943.
- Laberge J.M., Patenaude Y., Desilets V. et al. Large hepatic mesenchymal hamartoma leading to mid- trimester fetal demise // Fetal. Diagn. Ther. - 2005. - Vol. 20, № 2. - P. 141-145.
- Lau M.M.H., Stewart C.E.H., Liu Z. et al. Loss of the imprinted Igf2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality // Genes Dev. - 1994. - Vol. 8. - P. 2953-2963.
- Lokan J., Chan Y.F. Placental mesenchymal dysplasia // Pathology. - 2002. - Vol. 34, № 4. - P.~375-383.
- Maher E.R., Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited // J. Clin. Invest. - 2000. - Vol. 105, № 3. - P. 247-252.
- Matsui H., Iitsuka Y., Yamazawa K. et al. Placental mesenchymal dysplasia initially diagnosed as partial mole // Pathol. Int. - 2003. - Vol. 53, № 11. - P. 810-813.
- Matsuoka S., Thompson J.S., Edwards M.C. et al. Imprinting of the gene encoding a human cyclin- dependent kinase inhibitor, p57KIP2, on chromosome 11p15 // Proc. Natl. Acad. Sci. USA. - 1996. - Vol. 93, № 7. - P. 3026-3030.
- Moscoso G., Jauniaux E., Hustin J. Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity? // Pathol. Res. Pract. - 1991. - Vol. 187, № 2-3. - P. 324-328.
- Ohyama M., Kojyo T., Gotoda H. et al. Mesenchymal dysplasia of the placenta // Pathol. Int. - 2000. - Vol. 50, № 9. - P. 759-764.
- Paradinas F.J., Sebire N.J., Fisher R.A. et al. Pseudo- partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles // Histopathology. - 2001. - Vol. 39, № 5. - P. 447-454.
- Parveen Z., Tongson-Ignacio J.E., Fraser C.R. et al. Placental Mesenchymal Dysplasia. // Arch. Pathol. Lab. Med. - 2007. - Vol.131. - P. 131-137.
- Pham T., Steele J., Stayboldt C. et al. Placental mes- enchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise // Am. J. Clin. Pathol. - 2006. - Vol. 126, № 1. - P. 67-78.
- Ping A.J., Reeve A.E., Law D.J. et al. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15 // Am. J. Hum. Genet. - 1989. - Vol. 44, № 5. - P. 720-723.
- Sander C.M. Angiomatous malformation of placental chorionic stem vessels and pseudo-partial molar placentas: report of five cases // Pediatr. Pathol. - 1993. - Vol. 13, № 5. - P. 621-633.
- Yamada Y., Nezu J., Shimane M., Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D // Genomics. - 1997. - Vol. 42, № 3. - P. 483-488.
- Zhang P., Liegeois N.J., Wong C. et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome // Nature. - 1997. - Vol. 387, № 6629. - P. 151-158.
Дополнительные файлы
